Edward L. Coles

Array ( [id] => 3495461 [patent_doc_number] => 05532152 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-07-02 [patent_title] => 'Platelet-activating factor acetylhydrolase' [patent_app_type] => 1 [patent_app_number] => 8/470187 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7588 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/532/05532152.pdf [firstpage_image] =>[orig_patent_app_number] => 470187 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3998675 [patent_doc_number] => 05858705 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-12 [patent_title] => 'Polynucleotides encoding human DNA ligase III and methods of using these polynucleotides' [patent_app_type] => 1 [patent_app_number] => 8/464402 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 13784 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/858/05858705.pdf [firstpage_image] =>[orig_patent_app_number] => 464402 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3516285 [patent_doc_number] => 05529771 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-06-25 [patent_title] => 'Leukoregulin anti-herpes treatment' [patent_app_type] => 1 [patent_app_number] => 8/348838 [patent_app_country] => US [patent_app_date] => 1994-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 3013 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/529/05529771.pdf [firstpage_image] =>[orig_patent_app_number] => 348838 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3560703 [patent_doc_number] => 05525501 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-06-11 [patent_title] => 'DNA Fragment encoding acylamino acid racemase' [patent_app_type] => 1 [patent_app_number] => 8/347221 [patent_app_country] => US [patent_app_date] => 1994-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 6684 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/525/05525501.pdf [firstpage_image] =>[orig_patent_app_number] => 347221 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4035841 [patent_doc_number] => 05856298 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-05 [patent_title] => 'Erythropoietin isoforms' [patent_app_type] => 1 [patent_app_number] => 8/334882 [patent_app_country] => US [patent_app_date] => 1994-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10761 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/856/05856298.pdf [firstpage_image] =>[orig_patent_app_number] => 334882 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3560308 [patent_doc_number] => 05525472 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-06-11 [patent_title] => 'Method for production and purification or recombinant Apolipoprotein E from bacteria' [patent_app_type] => 1 [patent_app_number] => 8/333872 [patent_app_country] => US [patent_app_date] => 1994-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 13260 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 219 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/525/05525472.pdf [firstpage_image] =>[orig_patent_app_number] => 333872 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3528707 [patent_doc_number] => 05541309 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-07-30 [patent_title] => 'Modified apoaequorin having increased bioluminescent activity' [patent_app_type] => 1 [patent_app_number] => 8/331379 [patent_app_country] => US [patent_app_date] => 1994-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14053 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/541/05541309.pdf [firstpage_image] =>[orig_patent_app_number] => 331379 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3525234 [patent_doc_number] => 05541088 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-07-30 [patent_title] => 'Recombinant process of producing non-glycosylated B-cell defferentiation factor' [patent_app_type] => 1 [patent_app_number] => 8/309612 [patent_app_country] => US [patent_app_date] => 1994-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 37 [patent_no_of_words] => 19774 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 264 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/541/05541088.pdf [firstpage_image] =>[orig_patent_app_number] => 309612 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3516387 [patent_doc_number] => 05512661 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-04-30 [patent_title] => 'Multitrophic and multifunctional chimeric neurotrophic factors' [patent_app_type] => 1 [patent_app_number] => 8/308625 [patent_app_country] => US [patent_app_date] => 1994-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 28 [patent_no_of_words] => 18217 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/512/05512661.pdf [firstpage_image] =>[orig_patent_app_number] => 308625 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3586830 [patent_doc_number] => 05516659 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-05-14 [patent_title] => 'Truncated thrombomodulin, recombinant production thereof, and therapeutic agent' [patent_app_type] => 1 [patent_app_number] => 8/307444 [patent_app_country] => US [patent_app_date] => 1994-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 15701 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/516/05516659.pdf [firstpage_image] =>[orig_patent_app_number] => 307444 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3494230 [patent_doc_number] => 05508263 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-04-16 [patent_title] => 'Heterodimeric osteogenic factor' [patent_app_type] => 1 [patent_app_number] => 8/298021 [patent_app_country] => US [patent_app_date] => 1994-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 17 [patent_no_of_words] => 17375 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 174 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/508/05508263.pdf [firstpage_image] =>[orig_patent_app_number] => 298021 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3490676 [patent_doc_number] => 05508031 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-04-16 [patent_title] => 'Method for treating biological damage using a free-radial scavenger and interleukin-2' [patent_app_type] => 1 [patent_app_number] => 8/289844 [patent_app_country] => US [patent_app_date] => 1994-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12147 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/508/05508031.pdf [firstpage_image] =>[orig_patent_app_number] => 289844 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3715579 [patent_doc_number] => 05616562 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-01 [patent_title] => 'Methods and compositions using substance P to promote wound healing' [patent_app_type] => 1 [patent_app_number] => 8/279991 [patent_app_country] => US [patent_app_date] => 1994-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 17 [patent_no_of_words] => 8071 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/616/05616562.pdf [firstpage_image] =>[orig_patent_app_number] => 279991 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3457978 [patent_doc_number] => 05468483 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-11-21 [patent_title] => 'Bacillus thuringiensis anti-giardia treatment' [patent_app_type] => 1 [patent_app_number] => 8/278685 [patent_app_country] => US [patent_app_date] => 1994-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6663 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/468/05468483.pdf [firstpage_image] =>[orig_patent_app_number] => 278685 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3551972 [patent_doc_number] => 05573940 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-11-12 [patent_title] => 'Cells expressing high levels of CD59' [patent_app_type] => 1 [patent_app_number] => 8/271562 [patent_app_country] => US [patent_app_date] => 1994-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 9503 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/573/05573940.pdf [firstpage_image] =>[orig_patent_app_number] => 271562 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3515973 [patent_doc_number] => 05576288 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-11-19 [patent_title] => 'Fibroblast growth factor conjugates' [patent_app_type] => 1 [patent_app_number] => 8/257958 [patent_app_country] => US [patent_app_date] => 1994-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 5191 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/576/05576288.pdf [firstpage_image] =>[orig_patent_app_number] => 257958 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3551469 [patent_doc_number] => 05543140 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-08-06 [patent_title] => 'Method and use of IL-1.alpha.' [patent_app_type] => 1 [patent_app_number] => 8/252229 [patent_app_country] => US [patent_app_date] => 1994-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 11 [patent_no_of_words] => 10851 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/543/05543140.pdf [firstpage_image] =>[orig_patent_app_number] => 252229 [rel_patent_id] =>[rel_patent_doc_number] =>)